Atle Fund Management AB
Holdings as of 2026-06-30, filed 2026-07-24
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 24 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
39
Value reported by manager
$371.7M
Sum of our stored positions
$371.7M
should match the line above
Disclosure lag
24 d
quarter end to filing
Top 5 concentration
30.4%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
39 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| ELI LILLY & CO | COM | $35.8M | 29,821 | — | 532457108 |
| MERCK & CO. INC | COM | $24.3M | 189,357 | — | 58933Y105 |
| JOHNSON & JOHNSON | COM | $21.7M | 85,425 | — | 478160104 |
| ABBVIE INC | COM | $16.2M | 64,325 | — | 00287Y109 |
| CVS HEALTH CORP | COM | $15.1M | 146,102 | — | 126650100 |
| THERMO FISHER SCIENTIFIC CORP | COM | $14M | 27,859 | — | 883556102 |
| REVOLUTION MEDICINES INC | COM | $13.7M | 73,077 | — | 76155X100 |
| BIOGEN INC | COM | $13.6M | 62,781 | — | 09062X103 |
| NEUROCRINE BIOSCIENCES INC | COM | $12.3M | 72,898 | — | 64125C109 |
| MIRUM PHARMACEUTICALS INC | COM | $11.8M | 100,807 | — | 604749101 |
| ALKERMES PLC | SHS | $11.2M | 213,329 | — | G01767105 |
| IONIS PHARMACEUTICALS INC | COM | $10.9M | 137,131 | — | 462222100 |
| BEONE MEDICINES LTD-ADR | SPONSORED ADS | $10M | 35,180 | — | 07725L102 |
| INTUITIVE SURGICAL INC | COM NEW | $9.8M | 24,656 | — | 46120E602 |
| STRYKER CORPORATION | COM | $9.5M | 30,283 | — | 863667101 |
| VERTEX PHARMACEUTICALS INC | COM | $9.5M | 19,131 | — | 92532F100 |
| EDWARDS LIFESCIENCES CORP | COM | $9.3M | 103,230 | — | 28176E108 |
| BRIDGEBIO PHARMA INC | COM | $9.3M | 124,707 | — | 10806X102 |
| KRYSTAL BIOTECH, INC | COM | $8.9M | 24,019 | — | 501147102 |
| CENCORA INC | COM | $8.8M | 31,126 | — | 03073E105 |
| NEWAMSTERDAM PHARMA CO NV | ORDINARY SHARES | $8.4M | 248,848 | — | N62509109 |
| ABIVAX SA | SPONSORED ADS | $7.8M | 58,170 | — | 00370M103 |
| INCYTE CORP | COM | $6.5M | 56,953 | — | 45337C102 |
| IRHYTHM TECHNOLOGIES INC | COM | $6.4M | 54,102 | — | 450056106 |
| BOSTON SCIENTIFC | COM | $6.2M | 146,381 | — | 101137107 |
| INSMED INC | COM PAR $.01 | $6.2M | 58,378 | — | 457669307 |
| TANGO THERAPEUTICS INC | COM | $6.2M | 198,557 | — | 87583X109 |
| GILEAD SCIENCES INC | COM | $5.8M | 46,142 | — | 375558103 |
| CARDINAL HEALTH INC | COM | $5.6M | 23,630 | — | 14149Y108 |
| ORUKA THERAPEUTI | COM | $5.2M | 54,886 | — | 687604108 |
| SPYRE THERAPEUTICS INC | COM NEW | $5.1M | 57,030 | — | 00773J202 |
| DEXCOM INC | COM NEW | $4.8M | 71,846 | — | 252131107 |
| BICARA THERAPEUTICS INC | COM | $4.3M | 145,657 | — | 055477103 |
| IDEAYA BIOSCIENCES INC | COM | $3.5M | 94,478 | — | 45166A102 |
| CELCUITY INC | COM | $3.5M | 33,313 | — | 15102K100 |
| DISC MEDICINE INC | COM | $3.2M | 43,682 | — | 254604101 |
| PYXIS ONCOLOGY INC | COMMON STOCK | $2.9M | 966,459 | — | 747324101 |
| COMPASS THERAPEUTICS INC | COM | $2.3M | 1,048,593 | — | 20454B104 |
| JADE BIOSCIENCES | COM NEW | $2M | 88,556 | — | 008064206 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-07-24